These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31907674)

  • 1. Physiologically Based Pharmacokinetic Model to Support Ophthalmic Suspension Product Development.
    Le Merdy M; Tan ML; Babiskin A; Zhao L
    AAPS J; 2020 Jan; 22(2):26. PubMed ID: 31907674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension.
    Le Merdy M; Fan J; Bolger MB; Lukacova V; Spires J; Tsakalozou E; Patel V; Xu L; Stewart S; Chockalingam A; Narayanasamy S; Rouse R; Matta M; Babiskin A; Kozak D; Choi S; Zhang L; Lionberger R; Zhao L
    AAPS J; 2019 May; 21(4):65. PubMed ID: 31111305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations.
    Le Merdy M; Spires J; Lukacova V; Tan ML; Babiskin A; Xu X; Zhao L; Bolger MB
    Pharm Res; 2020 Nov; 37(12):245. PubMed ID: 33215336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
    Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y
    Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular distribution, bactericidal activity and settling characteristics of TobraDex ST ophthalmic suspension compared with TobraDex ophthalmic suspension.
    Scoper SV; Kabat AG; Owen GR; Stroman DW; Kabra BP; Faulkner R; Kulshreshtha AK; Rusk C; Bell B; Jamison T; Bernal-Perez LF; Brooks AC; Nguyen VA
    Adv Ther; 2008 Feb; 25(2):77-88. PubMed ID: 18309465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic prediction of the ocular absorption of an instilled drug with ophthalmic viscous vehicle.
    Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
    Biol Pharm Bull; 2000 Nov; 23(11):1352-6. PubMed ID: 11085365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.
    Kassem MA; Abdel Rahman AA; Ghorab MM; Ahmed MB; Khalil RM
    Int J Pharm; 2007 Aug; 340(1-2):126-33. PubMed ID: 17600645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucoadhesive chitosan-coated cationic microemulsion of dexamethasone for ocular delivery: in vitro and in vivo evaluation.
    Kesavan K; Kant S; Singh PN; Pandit JK
    Curr Eye Res; 2013 Mar; 38(3):342-52. PubMed ID: 23216079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.
    Deng F; Ranta VP; Kidron H; Urtti A
    Pharm Res; 2016 Nov; 33(11):2680-90. PubMed ID: 27431864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular pharmacokinetics profile of different indomethacin topical formulations.
    Bucolo C; Melilli B; Piazza C; Zurria M; Drago F
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):571-6. PubMed ID: 22059858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Ocular Exposure Extrapolation for Ophthalmic Solutions Using PBPK Modeling and Simulation.
    Le Merdy M; AlQaraghuli F; Tan ML; Walenga R; Babiskin A; Zhao L; Lukacova V
    Pharm Res; 2023 Feb; 40(2):431-447. PubMed ID: 36151444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops.
    Loftsson T; Hreinsdóttir D; Stefánsson E
    J Pharm Pharmacol; 2007 May; 59(5):629-35. PubMed ID: 17524227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
    Proksch JW; Ward KW
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):449-58. PubMed ID: 20874668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical pharmacokinetics of dexamethasone suspensions in the rabbit eye: Bioavailability comparison.
    Naageshwaran V; Ranta VP; Toropainen E; Tuomainen M; Gum G; Xie E; Bhoopathy S; Urtti A; Del Amo EM
    Int J Pharm; 2022 Mar; 615():121515. PubMed ID: 35091006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans.
    Proksch JW; Granvil CP; Siou-Mermet R; Comstock TL; Paterno MR; Ward KW
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):335-44. PubMed ID: 19492955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the release profile and pharmacokinetics of intact and fragmented dexamethasone intravitreal implants in rabbit eyes.
    Bhagat R; Zhang J; Farooq S; Li XY
    J Ocul Pharmacol Ther; 2014 Dec; 30(10):854-8. PubMed ID: 25411827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New vehicle based on a microemulsion for topical ocular administration of dexamethasone.
    Fialho SL; da Silva-Cunha A
    Clin Exp Ophthalmol; 2004 Dec; 32(6):626-32. PubMed ID: 15575833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ocular bioavailability comparison in rabbits of prednisolone acetate after repeated topical applications formulated as a high-viscosity gel and as an aqueous suspension.
    Johansen S; Rask-Pedersen E; Prause JU
    Acta Ophthalmol Scand; 1996 Jun; 74(3):259-64. PubMed ID: 8828723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ocular penetration of dexamethasone sodium phosphate via soft contact lenses].
    Goto S; Fujiwara H; Egi K; Katayama T; Suzuki T
    Nippon Ganka Gakkai Zasshi; 1989 Feb; 93(2):254-7. PubMed ID: 2788978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of the African green monkey as a preclinical model for ocular pharmacokinetic studies.
    Glogowski S; Ward KW; Lawrence MS; Goody RJ; Proksch JW
    J Ocul Pharmacol Ther; 2012 Jun; 28(3):290-8. PubMed ID: 22235843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.